A. James Moser - Concepedia

Author

A. James Moser

Beth Israel Deaconess Medical Center ORCID

Also Known As

A James J. Moser, A James Moser, A Moser, A. J. Moser, A. James Moser, A. Moser, A. Möser, A.J. Moser, Andreas A. Moser, Arthur J Moser

174

Publications

Citations

H-Index

Concepts

All Affiliations

Beth Israel Deaconess Medical Center University of Pittsburgh University of Pittsburgh Medical Center Harvard University UPMC Hillman Cancer Center

About

A. James Moser is an author at Beth Israel Deaconess Medical Center specializing in medicine, surgery, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	35	2.4K
2	Health Sciences	4	4	224
3	Engineering	3	3	169
4	Education	1	1	34
5	Public Health	1	1	86

A. James Moser

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
250 Robotic Pancreatic Resections Amer H. Zureikat, A. James Moser, Brian A. Boone, Annals of Surgery	2013	376
Assessment of Quality Outcomes for Robotic Pancreaticoduodenectomy Brian A. Boone, Mazen S. Zenati, Melissa E. Hogg, JAMA Surgery	2015	363
Robot-Assisted Minimally Invasive Distal Pancreatectomy Is Superior to the Laparoscopic Technique Mustapha Daouadi, Amer H. Zureikat, Mazen S. Zenati, Annals of Surgery	2012	331
Non-functional Neuroendocrine Carcinoma of the Pancreas: Incidence, Tumor Biology, and Outcomes in 2,158 Patients Jan Franko, Wentao Feng, Linwah Yip, Journal of Gastrointestinal Surgery Neuro-oncologySurgical OncologyPancreatic CancerMedicineNeuroendocrine Disorder	2009	278
Safety and Biologic Response of Pre-operative Autophagy Inhibition in Combination with Gemcitabine in Patients with Pancreatic Adenocarcinoma Brian A. Boone, Nathan Bahary, Amer H. Zureikat, Annals of Surgical Oncology Cell AutophagyTranslational MedicineMitophagyOncologyPre-operative Autophagy Inhibition	2015	231
Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer Ramesh K. Ramanathan, Kenneth Lee, John McKolanis, Cancer Immunology Immunotherapy Muc1 PeptidePancreatic CancerMedicineImmunologyTumor Immunity	2004	217
500 Minimally Invasive Robotic Pancreatoduodenectomies Amer H. Zureikat, Joal D. Beane, Mazen S. Zenati, Annals of Surgery	2019	191
A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors. Andrew J. Lepisto, A. James Moser, Herbert J. Zeh, PubMed Muc1 PeptidePhase I/ii StudyImmunologyPathologyCd4 T Cell Responses	2008	190
The learning curve for robotic distal pancreatectomy: an analysis of outcomes of the first 100 consecutive cases at a high‐volume pancreatic centre Murtaza Shakir, Brian A. Boone, Patricio M. Polanco, HPB Surgical TrainingPancreatic SurgeryLearning CurveSurgeryRobotic Distal Pancreatectomy	2015	183
Assessing the Accuracy and Readability of Online Health Information for Patients With Pancreatic Cancer Alessandra Storino, Manuel Castillo‐Angeles, Ammara A. Watkins, JAMA Surgery	2016	175

Page 1